Anacor Pharmaceuticals - Top 20 Biotech VC Deals of 2009
Company: Anacor Pharmaceuticals
Based: Palo Alto, CA
Amount: $50 million
Investors: GlaxoSmithKline, Schering Corporation, Rho Capital Partners, Venrock Associates, Care Capital and Aberdare Ventures
Scoop: Proceeds from the financing will be used to further develop Anacor's five clinical programs and to identify and progress new compounds derived the company's boron chemistry platform.
Related Articles:
Anacor regains anti-fungal drug rights from Merck
GSK willing to pay big for Anacor's anti-infectives
SHARE
WITH: